1 min read
BioCardia Beats Q3 GAAP Loss Per Share Estimate by One Cent
Net cash used in operations was $1.7 million, matching the year-earlier quarter.
BioCardia, Inc. (NASDAQ: BCDA) posted a GAAP loss of $0.12 per share for the third quarter of 2026, beating the estimate by $0.01.
Net cash used in operations was $1.7 million for the three months ended September 2026, matching the $1.7 million recorded in the same period in 2025.